177 related articles for article (PubMed ID: 1699946)
1. Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells.
Hochhuth C; Berkovic D; Eibl H; Unger C; Doenecke D
J Cancer Res Clin Oncol; 1990; 116(5):459-66. PubMed ID: 1699946
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C
Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410
[TBL] [Abstract][Full Text] [Related]
3. Effect of the anti-neoplastic agents edelfosine (ET-18-OCH3), ilmofosine (BM 41.440) and the hexadecylphosphocholine analogues D-20133 and D-21266 on histamine release from isolated rat mast cells.
Grosman N
Immunopharmacology; 1999 Nov; 44(3):211-21. PubMed ID: 10598878
[TBL] [Abstract][Full Text] [Related]
4. Morphological changes of adherent and nonadherent cells by treatment with hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine observed by scanning electron microscopy.
Kaufmann-Kolle P; Fleer EA
Prog Exp Tumor Res; 1992; 34():47-58. PubMed ID: 1438802
[No Abstract] [Full Text] [Related]
5. Effect of ether lipids on mouse granulocyte-macrophage progenitor cells.
Vehmeyer K; Kim DJ; Nagel GA; Eibl H; Unger C
Cancer Chemother Pharmacol; 1989; 24(1):58-60. PubMed ID: 2720891
[TBL] [Abstract][Full Text] [Related]
6. Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells.
Shoji M; Raynor RL; Fleer EA; Eibl H; Vogler WR; Kuo JF
Lipids; 1991 Feb; 26(2):145-9. PubMed ID: 2051897
[TBL] [Abstract][Full Text] [Related]
7. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
Wagner BA; Buettner GR; Burns CP
Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
[TBL] [Abstract][Full Text] [Related]
8. Quaternary ammonium analogs of ether lipids inhibit the activation of protein kinase C and the growth of human leukemia cell lines.
Civoli F; Daniel LW
Cancer Chemother Pharmacol; 1998; 42(4):319-26. PubMed ID: 9744778
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action.
Diomede L; Colotta F; Piovani B; Re F; Modest EJ; Salmona M
Int J Cancer; 1993 Jan; 53(1):124-30. PubMed ID: 8416196
[TBL] [Abstract][Full Text] [Related]
10. The antiproliferative effect of hexadecylphosphocholine toward HL60 cells is prevented by exogenous lysophosphatidylcholine.
Boggs K; Rock CO; Jackowski S
Biochim Biophys Acta; 1998 Jan; 1389(1):1-12. PubMed ID: 9443598
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Small GW; Strum JC; Daniel LW
Lipids; 1997 Jul; 32(7):715-23. PubMed ID: 9252959
[TBL] [Abstract][Full Text] [Related]
12. Hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine: a comparison of hemolytic activity, serum binding and tissue distribution.
Kötting J; Marschner NW; Neumüller W; Unger C; Eibl H
Prog Exp Tumor Res; 1992; 34():131-42. PubMed ID: 1438796
[No Abstract] [Full Text] [Related]
13. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
14. The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells.
Mollinedo F; Gajate C; Modolell M
Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):325-9. PubMed ID: 8092982
[TBL] [Abstract][Full Text] [Related]
15. The effect of two synthetic phospholipids on cell proliferation and phosphatidylcholine biosynthesis in Madin-Darby canine kidney cells.
Wieder T; Haase A; Geilen CC; Orfanos CE
Lipids; 1995 May; 30(5):389-93. PubMed ID: 7637558
[TBL] [Abstract][Full Text] [Related]
16. Increased cell-surface receptor expression on U-937 cells induced by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
Pushkareva MY; Wannberg SL; Janoff AS; Mayhew E
Cancer Immunol Immunother; 2000 Jan; 48(10):569-78. PubMed ID: 10630309
[TBL] [Abstract][Full Text] [Related]
17. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues.
Berkovic D; Haase D; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Nov; 1(6):368-75. PubMed ID: 9414427
[TBL] [Abstract][Full Text] [Related]
18. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines.
Shoji M; Fukuhara T; Winton EF; Berdel WE; Vogler WR
Exp Hematol; 1994 Jan; 22(1):13-8. PubMed ID: 8282054
[TBL] [Abstract][Full Text] [Related]
19. The antitumor phospholipid analog, hexadecylphosphocholine, activates cellular phospholipase D.
Wieder T; Zhang Z; Geilen CC; Orfanos CE; Giuliano AE; Cabot MC
Cancer Lett; 1996 Feb; 100(1-2):71-9. PubMed ID: 8620456
[TBL] [Abstract][Full Text] [Related]
20. Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KB.
Fleer EA; Berkovic D; Grunwald U; Hiddemann W
Eur J Cancer; 1996 Mar; 32A(3):506-11. PubMed ID: 8814699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
